Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients
The purpose of this study is to determine Effect of oral L-carnitine supplement on lipid profile, anemia, and quality of life.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
|Official Title:||Study of Treatment of Dyslipidemia for Hemodialysis|
- lipid profile [ Time Frame: at sixteen weeks after admission ] [ Designated as safety issue: Yes ]
- anemia [ Time Frame: at sixteen weeks after admission ] [ Designated as safety issue: Yes ]
- quality of life [ Time Frame: at sixteen weeks after admission ] [ Designated as safety issue: Yes ]
|Study Start Date:||August 2009|
|Study Completion Date:||September 2010|
|Primary Completion Date:||September 2010 (Final data collection date for primary outcome measure)|
it is as like as L-carnitine in shape
500 mg,twice daily, 16 weeks.
it is kind of supplement
500 mg,twice daily, 16 weeks
In patients under maintenance hemodialysis several factors reduce the body stored carnitine which in turn affected dyslipidemia, anemia, and general health in these patients. The investigators evaluated the effect of oral L-carnitine supplementation on lipid profiles, anemia, and quality of life in hemodialysis patients.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01278693
|Iran, Islamic Republic of|
|Noor university hospital|
|Isfahan, Iran, Islamic Republic of|
|Study Chair:||Mahnaz Moradi, MD||MD,research comittee|